Next Article in Journal
The Suppression of Columnar π-Stacking in 3-Adamantyl-1-phenyl-1,4-dihydrobenzo[e][1,2,4]triazin-4-yl
Next Article in Special Issue
Naturally Inspired Molecules as Multifunctional Agents for Alzheimer’s Disease Treatment
Previous Article in Journal
Recent Developments in Solid-Phase Extraction for Near and Attenuated Total Reflection Infrared Spectroscopic Analysis
Previous Article in Special Issue
Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer’s Disease
Open AccessArticle

Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease

1
Laboratory of Applied Chemistry, Heterocycles, Lipids and Polymers, Faculty of Sciences of Sfax, University of Sfax, B.P. 802, Sfax 3000, Tunisia
2
Laboratoire de Chimie Organique et Thérapeutique, Neurosciences Intégratives et Cliniques, EA 481, UFR SMP, Univ. Franche-Comté, Univ. Bourgogne Franche-Comté, 19, rue Ambroise Paré, Besançon F-25000, France
3
Laboratory of Cell Toxicology, EA 4267, University of Bourgogne Franche-Comté, 19 rue Ambroise Paré, Besançon Cedex 25030, France
4
Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, Ljubljana 1000, Slovenia
5
Department of Physicochemical Drug Analysis, Jagiellonian University Medical College, Medyczna 9 Street, Krakow 30-688, Poland
6
Laboratory of Medicinal Chemistry (IQOG, CSIC) C/Juan de la Cierva 3, Madrid 28006, Spain
7
Biomedical Research Center, University Hospital Hradec Kralove, 500 05 Hradec Králove, Czech Republic
*
Authors to whom correspondence should be addressed.
Present Address: Centre de Recherche de Gif-sur-Yvette, Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, Avenue de la Terrasse, Gif-sur-Yvette 91198, France.
Academic Editors: Michael Decker and Diego Muñoz-Torrero
Molecules 2016, 21(5), 634; https://doi.org/10.3390/molecules21050634
Received: 18 February 2016 / Revised: 19 April 2016 / Accepted: 4 May 2016 / Published: 14 May 2016
(This article belongs to the Special Issue Molecules against Alzheimer)
We report herein the straightforward two-step synthesis and biological assessment of novel racemic benzochromenopyrimidinones as non-hepatotoxic, acetylcholinesterase inhibitors with antioxidative properties. Among them, compound 3Bb displayed a mixed-type inhibition of human acetylcholinesterase (IC50 = 1.28 ± 0.03 μM), good antioxidant activity, and also proved to be non-hepatotoxic on human HepG2 cell line. View Full-Text
Keywords: Alzheimer’s disease; quinazolinones; multicomponent reactions; multitarget-directed ligands; antioxidants; cholinesterase inhibitors; hepatotoxicity Alzheimer’s disease; quinazolinones; multicomponent reactions; multitarget-directed ligands; antioxidants; cholinesterase inhibitors; hepatotoxicity
Show Figures

Figure 1

MDPI and ACS Style

Dgachi, Y.; Bautista-Aguilera, O.M.; Benchekroun, M.; Martin, H.; Bonet, A.; Knez, D.; Godyń, J.; Malawska, B.; Gobec, S.; Chioua, M.; Janockova, J.; Soukup, O.; Chabchoub, F.; Marco-Contelles, J.; Ismaili, L. Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease. Molecules 2016, 21, 634.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop